Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1219.0000 -11.70 (-0.95%)

NSE May 19, 2025 15:31 PM

Volume: 2.2M

Dr. Reddy's Laboratories Ltd.

06 Nov 2024

1219.00

-0.95%

Dr Reddy's Labs (HOLD): Healthy Q2; margins post gRevlimid LOE to remain wary

Hold: Dr. Reddy's Laboratories Ltd.

BOB Capital Markets Ltd.

Revenue/EBITDA earnings above our and street estimates. APAT ~46% above estimates. Estimates adjusted for JV and impairment cost

Dr. Reddy's Laboratories Ltd. is trading above its 100 day SMA of 1212.8